We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
HLK Biotech Holding Group Inc (CE) | USOTC:AMHD | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0002 | 0.00 | 00:00:00 |
Since then, we have been in talks with potential partners in Trinidad and Tobago, and expect to have agreements signed within the next few weeks.
Demand has been exceeding supply at our Barbados biodiesel production facility, which can be attributed to the extensive marketing campaign that was begun in December of 2009. We are now looking at cost effective ways in increasing production capability at our current facility.
A small profit was made in January; however, the last few months we have been basically breaking even, due to the fact that a large quantity of cooking oil we have collected in the last few months has been of different quality that increases the cost of processing. We have been contacting all the restaurants and hotels in Barbados, along with other sources of used cooking oil, and our oil collection has been steadily increasing. We are also considering the use of other feedstock to meet the increasing demand.
The current outstanding common shares balance is 4,309,573,155 and the number of authorized shares is 4,925,000,000. Mr. Guarnieri currently owns 736,275,000 shares of the Company's common stock. He has purchased 42,300,000 since January 19, 2010 in the open market through his online brokerage accounts. He has neither sold, pledged, assigned or transferred any of his purchased shares of the Company since becoming President in June 2009. There have been no issuances of additional shares since August 2008.
About Amelot Holdings, Inc. (PINKSHEETS: AMHD):
Amelot Holdings, Inc. (http://www.amelotholdings.com), a publicly traded company, is a diversified holding company that has identified Biodiesel as a multi-billion emerging Biofuel market. Amelot plans to have a significant market share in growing low cost feedstocks to supply the growing demand for biodiesel, to reduce energy dependency of fossil fuels, to help reduce the U.S. dependency on foreign oil supplies and reduce the impact of energy on our environment.
Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.
Contact: Amelot Holdings, Inc. 1(866)-669-8373 support@amelotholdings.com
1 Year HLK Biotech (CE) Chart |
1 Month HLK Biotech (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions